Business ❯ Pharmaceutical Industry

Investment

Research and Development Manufacturing Market Dynamics Innovation Market Trends AstraZeneca Research Funding UK Market Stock Market Market Conditions Corporate Investment Sanofi International Trade Market Agreements Pfizer Capital Expenditure Economic Policies UK Economy Manufacturing Facilities Strategic Partnerships Merck Life Sciences Corporate Governance Supply Chains US Pharma Firms International Collaboration Bristol Myers Squibb Healthcare Spending U.S. Market Foreign Direct Investment Corporate Strategy Manufacturing Expansion Corporate Decisions Government Support U.S. Manufacturing Market Opportunities Eli Lilly Venture Capital Foreign Investment NHS Spending Health Products Sector Investment in Mexico Agreements Production Facilities

Boehringer Ingelheim Transfers CT-155 Commercial Rights to Click Therapeutics With $50 Million Backing

The move positions Click to seek FDA clearance for a software therapy that targets schizophrenia’s untreated negative symptoms.

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

U.S. and U.K. Seal Three-Year Zero‑Tariff Pharma Deal Tied to Higher NHS Drug Prices

Trump Jokes About COVID After RFK Jr. Coughs at Oval Office Pfizer Event

GSK Pledges $30 Billion U.S. Investment as UK Drug-Pricing Standoff Drives Pullbacks

BMS, BioNTech Small-Cell Lung Cancer Drug Posts 76% Tumor Reduction, Advances to Phase III

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

FDA Launches PreCheck to Accelerate U.S. Drug Manufacturing Approvals